↓ Skip to main content

Betahistine for Ménière's disease or syndrome

Overview of attention for article published in Cochrane database of systematic reviews, January 2001
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
20 tweeters

Citations

dimensions_citation
147 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Betahistine for Ménière's disease or syndrome
Published in
Cochrane database of systematic reviews, January 2001
DOI 10.1002/14651858.cd001873
Pubmed ID
Authors

Adrian James, Martin J Burton

Abstract

Menière's disease is characterised by attacks of hearing loss, tinnitus and disabling vertigo. Betahistine is used by many people to reduce the frequency and severity of these attacks but there is conflicting evidence relating to its effects. The objective of this review was to assess the effects of betahistine in people with Menière's disease. We searched the Cochrane Controlled Trials Register (The Cochrane Library issue 4,1999), MEDLINE (January 1966 to December 1999), EMBASE (January 1985 to December 1999) and Index Medicus (1962 to 1966). We checked reference lists of articles and contacted pharmaceutical companies for further studies. Randomised controlled studies of betahistine versus placebo in Menière's disease. Two reviewers independently assessed trial quality and extracted data. Study authors were contacted for further information. Six trials involving 162 patients were included. No trial met the highest quality standard set by the review because of inadequate diagnostic criteria or methods, and none assessed the effect of betahistine on vertigo adequately. Most trials suggested a reduction of vertigo with betahistine and some suggested a reduction in tinnitus but all these effects may have been caused by bias in the methods. One trial with good methods showed no effect of betahistine on tinnitus compared with placebo in 35 patients. None of the trials showed any effect of betahistine on hearing loss. No adverse effects were found with betahistine. There is insufficient evidence to say whether betahistine has any effect on Menière's disease.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 6%
Unknown 16 94%

Demographic breakdown

Readers by professional status Count As %
Other 7 41%
Student > Bachelor 5 29%
Student > Ph. D. Student 5 29%
Student > Master 5 29%
Student > Postgraduate 4 24%
Other 8 47%
Readers by discipline Count As %
Medicine and Dentistry 20 118%
Unspecified 3 18%
Business, Management and Accounting 3 18%
Pharmacology, Toxicology and Pharmaceutical Science 2 12%
Psychology 2 12%
Other 4 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2019.
All research outputs
#1,389,659
of 13,644,932 outputs
Outputs from Cochrane database of systematic reviews
#3,926
of 10,697 outputs
Outputs of similar age
#18,474
of 163,521 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 113 outputs
Altmetric has tracked 13,644,932 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,697 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,521 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.